基于网络药理学和分子对接探讨桃仁红花煎治疗心律失常的作用机制
Exploring the Mechanism of Action of Taoren Honghua Decoction in the Treatment of Cardiac Arrhythmias Based on Network Pharmacology and Molecular Docking
DOI: 10.12677/ACM.2022.1210337, PDF,  被引量   
作者: 陈明瑞:济宁医学院临床医学院,山东 济宁;魏广和*:济宁医学院附属医院心内一科,山东 济宁
关键词: 桃仁红花煎心律失常网络药理学分子对接作用机制Taoren Honghua Decoction Cardiac Arrhythmia Network Pharmacology Molecular Docking Mechanism of Action
摘要: 目的:基于网络药理学和分子对接的方法探讨桃仁红花煎治疗心律失常的有效成分、作用靶点及其作用机制。方法:通过TCMSP、TCM-ID筛选桃仁红花煎的有效成分并预测其作用靶点,对成分–靶点网络拓扑分析后得到主要有效成分。在GeenCards、DisGeNET、Drugbank及TTD数据库获得心律失常靶点,对交集靶点进行蛋白蛋白相互作用(PPI)筛选出关键靶点,并进行基因本体论(GO)和京都基因与基因百科全书(KEGG)富集参与的生物学过程及信号通路,最后通过分子对接验证成分与靶点的结合程度。结果:筛选出中药主要成分为Lactiflorin、(2R,3R)-4-methoxyl-distylin、Gibberellin A19、Gibberellin A30、Gibberellin A54、Gibberellin A60、Fumaricine、13-methylpalmatrubine、N-methyllaurotetanine;关键靶点为RHOA、EGFR、SRC、STAT3、RAC1、FYN。KEGG表明钙信号通路、cAMP等信号通路在治疗心律失常中发挥主要作用,分子对接结果提示中药成分能够与关键靶点稳定结合。结论:桃仁红花煎治疗心律失常的分子机制较为复杂,本研究为进一步揭示其药理作用提供了新的思路。
Abstract: Objective: To investigate the active ingredients, action targets and their mechanisms of action of Taoren Honghua decoction in the treatment of cardiac arrhythmias based on network pharmacolo-gy and molecular docking methods. Methods: The active ingredients of Taoren Honghua decoction were screened by TCMSP and TCM-ID and their targets of action were predicted, and the main active ingredients were obtained after topological analysis of the ingredient-target network. Arrhythmia targets were obtained in GeenCards, DisGeNET, Drugbank and TTD databases, protein-protein in-teractions (PPI) were performed on the intersecting targets to screen out the key targets, and gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed to enrich the biological processes and signaling pathways involved, and finally the degree of binding of the com-ponents to the targets was verified by molecular docking. Results: The main components of the Chinese medicine were screened as Lactiflorin, (2R,3R)-4-methoxyl-distylin, Gibberellin A19, Gib-berellin A30, Gibberellin A54, Gibberellin A60, Fumaricine, 13-methylpalmatrubine, N-methyllaurotetanine; the key targets were RHOA, EGFR, SRC, STAT3, RAC1, FYN. KEGG indicated that calcium signaling pathways, cAMP and other signaling pathways play a major role in the treatment of cardiac arrhythmias, and the molecular docking results suggest that the herbal com-ponents can bind to the key targets stably. Conclusion: The molecular mechanism of Taoren Honghua decoction in the treatment of cardiac arrhythmias is complex, and this study provides a new idea to further reveal its pharmacological effects.
文章引用:陈明瑞, 魏广和. 基于网络药理学和分子对接探讨桃仁红花煎治疗心律失常的作用机制[J]. 临床医学进展, 2022, 12(10): 9243-9254. https://doi.org/10.12677/ACM.2022.1210337

参考文献

[1] Fu, D.G. (2015) Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments. Cell Biochemistry and Biophysics, 73, 291-296. [Google Scholar] [CrossRef] [PubMed]
[2] Varro, A., Nanasi, P.P., Acsai, K., et al. (2004) Cardiac Sarcolemmal Ion Channels and Transporters as Possible Targets for Antiarrhythmic and Positive Inotropic Drugs: Strate-gies of the Past—Perspectives of the Future. Current Pharmaceutical Design, 10, 2411-2427. [Google Scholar] [CrossRef] [PubMed]
[3] Habibi, M., Berger, R.D. and Calkins, H. (2021) Radiofrequency Ablation: Technological Trends, Challenges, and Opportunities. Europace, 23, 511-519. [Google Scholar] [CrossRef] [PubMed]
[4] 饶炼, 褚庆民, 洪创雄. 桃仁红花煎加减方治疗围产期心肌病并发反复室速室颤1例[J]. 中国中西医结合杂志, 2022, 42(6): 762-763.
[5] 谭巨浪, 胡晓军, 张臻, 等. 桃仁红花煎联合伊伐布雷定治疗血络瘀阻型持续性房颤的临床效果[J]. 中国当代医药, 2021, 28(16): 178-183.
[6] Luo, T.T., Lu, Y., Yan, S.K., et al. (2020) Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective. Chinese Journal of Integrative Medicine, 26, 72-80. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, W., Chen, Y., Jiang, H., et al. (2020) Integrated Strategy for Accurately Screening Biomarkers Based on Metabolomics Coupled with Network Pharmacology. Talanta, 211, Arti-cle ID: 120710. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, L., Duan, J.A., Tang, Y., et al. (2012) Taoren-Honghua Herb Pair and Its Main Components Promoting Blood Circulation through Influencing on Hemorheology, Plasma Coag-ulation and Platelet Aggregation. Journal of Ethnopharmacology, 139, 381-387. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, H., Hao, M., Li, L., et al. (2021) Shenxian-Shengmai Oral Liquid Improves Sinoatrial Node Dysfunction through the PKC/NOX-2 Signaling Pathway. Evidence-Based Comple-mentary and Alternative Medicine, 2021, Article ID: 5572140. [Google Scholar] [CrossRef] [PubMed]
[10] Qu, Z., Xie, L.H., Olcese, R., et al. (2013) Early after Depolarizations in Cardiac Myocytes: Beyond Reduced Repolarization Reserve. Cardiovascular Research, 99, 6-15. [Google Scholar] [CrossRef] [PubMed]
[11] Li, D., Long, Y., Yu, S., et al. (2021) Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum Chuanxiong Hort. Frontiers in Pharma-cology, 12, Article ID: 832673. [Google Scholar] [CrossRef] [PubMed]
[12] 李荣, 吴伟, 李文晞, 等. 延胡索碱预处理对缺血再灌注心肌钙泵及钠钾泵活性的影响[J]. 辽宁中医杂志, 2010, 37(8): 1613-1615.
[13] Manning, G., Whyte, D.B., Martinez, R., et al. (2002) The Protein Kinase Complement of the Human Genome. Science, 298, 1912-1934. [Google Scholar] [CrossRef] [PubMed]
[14] Roskoski Jr., R. (2004) SRC Protein-Tyrosine Kinase Structure and Regulation. Biochemical and Biophysical Research Communications, 324, 1155-1164. [Google Scholar] [CrossRef] [PubMed]
[15] Ueda, K., Nakamura, K., Hayashi, T., et al. (2004) Functional Characterization of a Trafficking-Defective HCN4 Mutation, D553N, Associated with Cardiac Arrhythmia. Journal of Biological Chemistry, 279, 27194-27198. [Google Scholar] [CrossRef
[16] Lin, Y.C., Huang, J., Kan, H., et al. (2009) Rescue of a Trafficking Defective Human Pacemaker Channel via a Novel Mechanism: Roles of Src, Fyn, and Yes Tyrosine Kinases. Journal of Biological Chemistry, 284, 30433-30440. [Google Scholar] [CrossRef
[17] Huang, J., Lin, Y.C., Hileman, S., et al. (2015) PP2 Prevents Iso-proterenol Stimulation of Cardiac Pacemaker Activity. Journal of Cardiovascular Pharmacology, 65, 193-202. [Google Scholar] [CrossRef
[18] Liao, Z., Lockhead, D., St Clair, J.R., et al. (2012) Cellular Context and Multiple Channel Domains Determine cAMP Sensitivity of HCN4 Channels: Ligand-Independent Relief of Autoinhibition in HCN4. Journal of General Physiology, 140, 557-566. [Google Scholar] [CrossRef] [PubMed]
[19] Rutledge, C.A., Ng, F.S., Sulkin, M.S., et al. (2014) c-Src Kinase In-hibition Reduces Arrhythmia Inducibility and Connexin43 Dysregulation after Myocardial Infarction. Journal of the American College of Cardiology, 63, 928-934. [Google Scholar] [CrossRef] [PubMed]
[20] Greiser, M., Halaszovich, C.R., Frechen, D., et al. (2007) Pharma-cological Evidence for Altered Src Kinase Regulation of I (Ca, L) in Patients with Chronic Atrial Fibrillation. Naunyn-Schmiedeberg’s Archives of Pharmacology, 375, 383-392. [Google Scholar] [CrossRef] [PubMed]
[21] Mosaddeghzadeh, N. and Ahmadian, M.R. (2021) The RHO Family GTPases: Mechanisms of Regulation and Signaling. Cells, 10, Article No. 1831. [Google Scholar] [CrossRef] [PubMed]
[22] Kelder, T.P., Vicente-Steijn, R., Poelmann, R.E., et al. (2019) Disrup-tion of RHOA-ROCK Signaling Results in Atrioventricular Block and Disturbed Development of the Putative Atrioven-tricular Node. The Anatomical Record (Hoboken), 302, 83-92. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, Y., Shao, C., Qi, L., et al. (2022) EphrinB2-RhoA Upregulation Attenuates Sympathetic Hyperinnervation and Decreases the Incidence of Ventricular Arrhythmia after Myocardial Infarction. Journal of Cardiology, 79, 423-431. [Google Scholar] [CrossRef] [PubMed]
[24] Adam, O., Lavall, D., Theobald, K., et al. (2010) Rac1-Induced Connective Tissue Growth Factor Regulates Connexin 43 and N-Cadherin Expression in Atrial Fibrillation. Journal of the American College of Cardiology, 55, 469-480. [Google Scholar] [CrossRef] [PubMed]
[25] Landstrom, A.P., Dobrev, D. and Wehrens, X.H.T. (2017) Calcium Signaling and Cardiac Arrhythmias. Circulation Research, 120, 1969-1993. [Google Scholar] [CrossRef
[26] Heijman, J., Algalarrondo, V., Voigt, N., et al. (2016) The Value of Basic Research Insights into Atrial Fibrillation Mechanisms as a Guide to Therapeutic Innovation: A Criti-cal Analysis. Cardiovascular Research, 109, 467-479. [Google Scholar] [CrossRef] [PubMed]
[27] Garnier, A., Bork, N.I., Jacquet, E., et al. (2021) Mapping Genetic Chang-es in the cAMP-Signaling Cascade in Human Atria. Journal of Molecular and Cellular Cardiology, 155, 10-20. [Google Scholar] [CrossRef] [PubMed]
[28] Li, S.S., Kang, N., Li, X.L., et al. (2021) LianXia Formula Gran-ule Attenuates Cardiac Sympathetic Remodeling in Rats with Myocardial Infarction via the NGF/TrKA/PI3K/AKT Sig-naling Pathway. Evidence-Based Complementary and Alternative Medicine, 2021, Article ID: 5536406. [Google Scholar] [CrossRef] [PubMed]
[29] De Jesus, N.M., Wang, L., Herren, A.W., et al. (2015) Atherosclerosis Exacerbates Arrhythmia Following Myocardial Infarction: Role of Myocardial Inflammation. Heart Rhythm, 12, 169-178. [Google Scholar] [CrossRef] [PubMed]
[30] Carrick, D., Haig, C., Rauhalammi, S., et al. (2015) Pathophysi-ology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis. JACC: Cardio-vascular Imaging, 8, 779-789. [Google Scholar] [CrossRef] [PubMed]
[31] Hsiao, Y.W., Tsai, Y.N., Huang, Y.T., et al. (2021) Rhodiola Crenulata Reduces Ventricular Arrhythmia through Mitigating the Activation of IL-17 and Inhibiting the MAPK Signal-ing Pathway. Cardiovascular Drugs and Therapy, 35, 889-900. [Google Scholar] [CrossRef] [PubMed]